The device uses passive-sweat sensor technology for non-invasive, continuous monitoring of cortisol and melatonin, offering real-time wellness insights.


Summary: A new wearable device, launching this summer, leverages proprietary sensor technology for non-invasive, continuous monitoring of cortisol and melatonin levels, providing real-time insights into stress and sleep. Originating from research on inflammation markers in autoimmune disorders, it now enables users to understand the impact of lifestyle choices on their health through over 3,000 weekly biomarker measurements. The technology behind this innovation, backed by a decade of research and over 500,000 biomarker readings, aims to enhance health awareness with advanced analytics and AI models in the upcoming year.

Key Takeaways:

  • Set to launch this summer, the device offers detailed insights into users’ stress and sleep patterns by monitoring cortisol and melatonin levels.
  • It allows users to track over 3,000 measurements for each biomarker weekly, enabling the observation of immediate and long-term lifestyle impacts on health.
  • The technology is supported by over a decade of research and development, including over 500,000 biomarker readings, with further enhancements planned through advanced analytics and AI models.

EnLiSense is set to launch Corti—a new wearable device that provides personalized monitoring of the key stress and sleep hormones, cortisol and melatonin—this summer.

The wearable features its proprietary passive-sweat sensor technology that non-invasively rests on the user’s skin, day and night, continuously measuring biomarker levels. Corti originated as a tool for identifying inflammation markers in autoimmune disorders. Now, it provides users with real-time insights into their wellness, establishing continuous monitoring of these biomarkers.

Monitoring for Everyday Health

Corti offers real-time visibility into the body’s stress and sleep hormones, cortisol and melatonin. These hormones undergo substantial fluctuations throughout the day, influenced by personal lifestyle choices. In fact, melatonin’s activity levels change within just 20 to 30 minutes, and cortisol levels typically peak 15 to 30 minutes after stress onset, each while influenced by their unique circadian pattern illustrating the complex daily journey of our hormones. 

Unlike traditional hormone assessments that often yield a single, less informative snapshot, Corti captures more than 3,000 measurements for each biomarker in a week. This data allows users to observe both the immediate and long-term effects their lifestyle decisions have on their health.

Users can uncover what triggers stress hormone spikes, see how melatonin levels align with their sleep readiness, and learn how diet, exercise, and other lifestyle choices impact these short-term and chronic stress levels.

A Future Focused on Advanced Health Insights

“Corti represents the latest evolution of our advanced passive-sweat sensor technology, underpinned by rigorous clinical validation,” says Shalini Prasad, PhD, professor and department head of bioengineering at the University of Texas at Dallas and co-founder of EnLiSense, in a release. “Building on our extensive inflammatory biomarker research, we are actively conducting additional clinical studies that further validate cortisol and melatonin monitoring into our technology, providing a non-intrusive way to proactively keep an eye on our health.

EnLiSense’s underlying technology boasts over a decade of research resulting in over 30 publications, with over 500,000 biomarker readings recorded in recent years demonstrating the technology’s robustness.

Throughout 2024, Corti will continue to introduce a range of functionalities for its Corti users, including advanced analytics dashboards and unique artificial intelligence models, designed to enhance users’ understanding of the dynamics of their stress and sleep hormones.

Illustration 90721324 © Flamestar | Dreamstime.com